Annual Working Capital
-$2.02 M
-$876.80 K-76.99%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual working capital is currently -$2.02 million, with the most recent change of -$876.80 thousand (-76.99%) on 31 December 2023. During the last 3 years, it has fallen by -$1.31 million (-186.97%). BLACU annual working capital is now -678.56% below its all-time high of -$258.90 thousand, reached on 01 December 2020.BLACU Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$3.90 M
-$650.20 K-20.00%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly working capital is currently -$3.90 million, with the most recent change of -$650.20 thousand (-20.00%) on 30 September 2024. Over the past year, it has dropped by -$2.88 million (-281.49%). BLACU quarterly working capital is now -14822.64% below its all-time high of $26.50 thousand, reached on 01 March 2023.BLACU Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.0% | -281.5% |
| 3 y3 years | -187.0% | -455.4% |
| 5 y5 years | - | - |
BLACU Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -187.0% | at low | <-9999.0% | at low |
| 5 y | 5 years | -678.6% | at low | <-9999.0% | at low |
| alltime | all time | -678.6% | at low | <-9999.0% | at low |
Bellevue Life Sciences Acquisit Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$3.90 M(+20.0%) |
| June 2024 | - | -$3.25 M(+21.5%) |
| Mar 2024 | - | -$2.68 M(+32.8%) |
| Dec 2023 | -$2.02 M | -$2.02 M(+97.1%) |
| Sept 2023 | - | -$1.02 M(+112.0%) |
| June 2023 | - | -$482.40 K(-1920.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $26.50 K(-102.3%) |
| Dec 2022 | -$1.14 M(+62.1%) | - |
| Dec 2022 | - | -$1.14 M(+2.0%) |
| Sept 2022 | - | -$1.12 M(+13.0%) |
| June 2022 | - | -$988.20 K(+40.7%) |
| Dec 2021 | -$702.40 K(+171.3%) | -$702.40 K |
| Dec 2020 | -$258.90 K | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual working capital?
- What is the all time high annual working capital for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual working capital year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly working capital?
- What is the all time high quarterly working capital for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly working capital year-on-year change?
What is Bellevue Life Sciences Acquisit annual working capital?
The current annual working capital of BLACU is -$2.02 M
What is the all time high annual working capital for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual working capital is -$258.90 K
What is Bellevue Life Sciences Acquisit annual working capital year-on-year change?
Over the past year, BLACU annual working capital has changed by -$876.80 K (-76.99%)
What is Bellevue Life Sciences Acquisit quarterly working capital?
The current quarterly working capital of BLACU is -$3.90 M
What is the all time high quarterly working capital for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly working capital is $26.50 K
What is Bellevue Life Sciences Acquisit quarterly working capital year-on-year change?
Over the past year, BLACU quarterly working capital has changed by -$2.88 M (-281.49%)